Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Bausch + Lomb Says Ophthalmology And Therapy Publishes Results From Phase 3 Study Assessing Efficacy, Safety Of LUMIFY Preservative Free Redness Reliever Eye Drops Versus LUMIFY Redness Reliever Eye Drops For Reducing Ocular Redness

Author: Benzinga Newsdesk | July 29, 2025 07:25am

Posted In: BLCO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist